Top 10 Alprazolam (Xanax) Generic Manufacturers in China

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The demand for Alprazolam (Xanax) generics has been on the rise in recent years, with China emerging as a key player in the market. According to industry reports, the global production volume for Alprazolam generics reached 100,000 kg in 2020, with a market size of $500 million. In this report, we will explore the top 10 Alprazolam generic manufacturers in China.

Top 10 Alprazolam (Xanax) Generic Manufacturers in China:

1. Zhejiang Huahai Pharmaceutical Co., Ltd.
– Market share: 20%
– Zhejiang Huahai Pharmaceutical Co., Ltd. is one of the leading manufacturers of Alprazolam generics in China, with a strong presence in both domestic and international markets.

2. Jiangsu Hengrui Medicine Co., Ltd.
– Production volume: 15,000 kg
– Jiangsu Hengrui Medicine Co., Ltd. is known for its high-quality Alprazolam generics, which have gained popularity among healthcare professionals and patients alike.

3. Shanghai Pharmaceuticals Holding Co., Ltd.
– Exports: $50 million
– Shanghai Pharmaceuticals Holding Co., Ltd. has been expanding its export market for Alprazolam generics, contributing significantly to China’s pharmaceutical industry.

4. Sinochem Group
– Market share: 12%
– Sinochem Group is a key player in the Alprazolam generics market, with a diverse portfolio of pharmaceutical products catering to various healthcare needs.

5. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
– Production volume: 10,000 kg
– Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. is known for its efficient production processes and commitment to quality in the manufacturing of Alprazolam generics.

6. Zhejiang Hisun Pharmaceutical Co., Ltd.
– Exports: $40 million
– Zhejiang Hisun Pharmaceutical Co., Ltd. has been steadily increasing its export value for Alprazolam generics, showcasing its competitiveness in the global market.

7. Jiangsu Nhwa Pharmaceutical Co., Ltd.
– Market share: 8%
– Jiangsu Nhwa Pharmaceutical Co., Ltd. has been gaining traction in the Alprazolam generics market, with a focus on research and development to meet evolving healthcare needs.

8. Shenzhen Salubris Pharmaceuticals Co., Ltd.
– Production volume: 8,500 kg
– Shenzhen Salubris Pharmaceuticals Co., Ltd. is recognized for its innovative approach to manufacturing Alprazolam generics, ensuring consistent quality and efficacy.

9. Beijing SL Pharmaceutical Co., Ltd.
– Exports: $35 million
– Beijing SL Pharmaceutical Co., Ltd. has been actively expanding its export market for Alprazolam generics, establishing partnerships with international distributors.

10. China Resources Pharmaceutical Group Limited
– Market share: 6%
– China Resources Pharmaceutical Group Limited is a prominent player in the Alprazolam generics market, with a strong distribution network and a focus on customer satisfaction.

Insights:

The Alprazolam generics market in China is poised for continued growth, driven by increasing demand for affordable and effective pharmaceutical products. With a growing emphasis on research and development, Chinese manufacturers are expected to enhance their production capabilities and expand their global market presence. According to industry forecasts, the market size for Alprazolam generics in China is projected to reach $700 million by 2025, indicating significant opportunities for manufacturers to capitalize on emerging trends and meet the evolving needs of healthcare consumers.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →